Cargando…
SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease
In Parkinson's disease (PD), cognitive functions mediated by brain regions innervated by ventral tegmental area (VTA) worsen with dopamine replacement therapy, whereas processes relying on regions innervated by the substantia nigra pars compacta (SNc) improve. The SLC6A3 gene encodes the dopami...
Autores principales: | Robertson, Brian D., Al Jaja, Abdullah S., MacDonald, Alex A., Hiebert, Nole M., Tamjeedi, Ruzbeh, Seergobin, Ken N., Schwarz, Ute I., Kim, Richard B., MacDonald, Penny A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110885/ https://www.ncbi.nlm.nih.gov/pubmed/30186226 http://dx.doi.org/10.3389/fneur.2018.00693 |
Ejemplares similares
-
Differential Effects of Parkinson's Disease and Dopamine Replacement on Memory Encoding and Retrieval
por: MacDonald, Alex A., et al.
Publicado: (2013) -
Examining dorsal striatum in cognitive effort using Parkinson's disease and fMRI
por: MacDonald, Alex A, et al.
Publicado: (2014) -
Dopaminergic therapy affects learning and impulsivity in Parkinson’s disease
por: Hiebert, Nole M, et al.
Publicado: (2014) -
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease
por: Vo, Andrew, et al.
Publicado: (2014) -
Biomarkers of Parkinson's disease: Striatal sub-regional structural morphometry and diffusion MRI
por: Khan, Ali R., et al.
Publicado: (2018)